+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Investigating Human Diseases with the Microbiome. Metagenomics Bench to Bedside

  • Book

  • February 2022
  • Elsevier Science and Technology
  • ID: 5446553

Investigating Human Diseases with the Microbiome: Metagenomics Bench to Bedside is a summary of underlying principles for human health and disease studies from a microbiome point-of-view. From birth to old age, microbiomes in fecal, oral/nasal, vaginal, and skin samples contain important information that can predict disease risks in the future. Tissue samples also contain microbes that are relevant for diseases. The microbiome connects genetic and environmental factors and is poised to greatly facilitate precision medicine, including prevention, diagnosis and effective treatment of many complex diseases.

Based in traditional microbiology and adding a more wholistic view of the advent of high-throughput sequencing, this reference poses the key questions of the total number of microbial cells and their distribution in the human body while also considering concepts from macroecology and from causal reasoning. An entire chapter is dedicated to methods, providing hands-on information for important considerations when collecting samples for metagenomic studies.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. The Supraorganism 2. Microbiota 3. Collecting samples for metagenomics 4. Epidemiology for the human body 5. The evolving microbial taxonomy 6. Blurring the line between opportunistic 'pathogens' and 'commensals' 7. Metagenomics from bench to bedside and from bedside to bench 8. A Microbiome record for life

Authors

Huijue Jia Director, Shenzhen Key Laboratory of Human Commensal Microorganisms and Health Research, BGI-Shenzhen; Mentor for graduate students, BGI Education Center, University of Chinese Academy of Sciences. Dr. Huijue Jia PhD has been pushing the boundaries of human microbiome and disease studies since returning back to China and joining BGI-Shenzhen by the end of 2012, and is the Director of the Shenzhen Key Laboratory of Human Commensal Microorganisms and Health Research where applies her extensive knowledge of the academic, clinical, and the corporate trends within the metagenomic field. She is a Co-Chair of the Million Microbiome of Humans Project (MMHP), the largest microbiome consortium after government funding ended for Metagenomics of the Human Intestinal Tract (MetaHIT) in Europe and then integrative Human Microbiome Project (iHMP) in the U.S. She is responsible for over 30 publications in this area of research with over 50% of them in the top citation percentile. She has served as Scientific Editor on Nature Communications and has contributed to reviews, commentaries, and other book projects.